COMP <GO>
MRX vs BAC // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Marex Group Limited (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: MRX 6
— BAC 6
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: BAC
LAST: $64.41 (-0.98%) • MKT CAP: $4.82B
options-implied-move
7.10%
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MRX VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MRX | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 2.50% | +7.40 | MRX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 30.2x | -9.20 | MRX | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.10% | +0.11 | MRX | /fcf-yield <GO> |
| Operating Margin | 13.90% | 32.90% | -19.00 | BAC | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 27.00% | -16.10 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 2.20% | 6.80% | -4.60 | BAC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 0.45 | +3.29 | MRX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.10% | 6.60% | +0.50 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.8 | 27.7 | +8.17 | MRX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.90 | +0.17 | MRX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 10.9x | +19.60 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.82B | $357.61B | -$352.79B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MRX REV | BAC REV | MRX GROSS % | BAC GROSS % | MRX FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $113.10B | — | 44.0% | — | $7.52B |
| FY 2024 | — | $105.86B | — | 44.0% | — | -$13.57B |
| FY 2023 | — | $102.77B | — | 44.0% | — | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MRX // BETA 1.07
BAC // BETA 0.90